Weight-loss surgery lowers risk of developing complications of liver disease in patients with cirrhosis and obesity
Steven Nissen, M.D., Chief Academic Officer of the Heart, Vascular and Thoracic Institute at Cleveland Clinic and the study's senior investigator, said: "Currently, lifestyle intervention is the only therapeutic recommendation for compensated MASH-related cirrhosis.